Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
Titel:
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
Auteur:
Di Bartolomeo, M. Pietrantonio, F. Perrone, F. Dotti, K. F. Lampis, A. Bertan, C. Beretta, E. Rimassa, L. Carbone, C. Biondani, P. Passalacqua, R. Pilotti, S. Bajetta, E.